- Home
- AKRO vs INTR Comparison
AKRO vs INTR Comparison
Compare AKRO & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- INTR
- Stock Information
- Founded
- AKRO 2017
- INTR 1994
- Country
- AKRO United States
- INTR Brazil
- Employees
- AKRO N/A
- INTR 3270
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- INTR
- Sector
- AKRO Health Care
- INTR
- Exchange
- AKRO Nasdaq
- INTR Nasdaq
- Market Cap
- AKRO 2.0B
- INTR 2.1B
- IPO Year
- AKRO 2019
- INTR N/A
- Fundamental
- Price
- AKRO $25.14
- INTR $4.73
- Analyst Decision
- AKRO Strong Buy
- INTR Strong Buy
- Analyst Count
- AKRO 8
- INTR 4
- Target Price
- AKRO $46.83
- INTR $7.13
- AVG Volume (30 Days)
- AKRO 842.7K
- INTR 1.9M
- Earning Date
- AKRO 02-27-2025
- INTR 02-05-2025
- Dividend Yield
- AKRO N/A
- INTR 2.54%
- EPS Growth
- AKRO N/A
- INTR 295.93
- EPS
- AKRO N/A
- INTR 0.33
- Revenue
- AKRO N/A
- INTR $767,729,562.00
- Revenue This Year
- AKRO N/A
- INTR N/A
- Revenue Next Year
- AKRO N/A
- INTR $23.65
- P/E Ratio
- AKRO N/A
- INTR $14.16
- Revenue Growth
- AKRO N/A
- INTR 38.44
- 52 Week Low
- AKRO $15.32
- INTR $3.88
- 52 Week High
- AKRO $37.00
- INTR $7.84
- Technical
- Relative Strength Index (RSI)
- AKRO 41.89
- INTR 56.92
- Support Level
- AKRO $21.34
- INTR $4.20
- Resistance Level
- AKRO $28.94
- INTR $4.44
- Average True Range (ATR)
- AKRO 1.38
- INTR 0.13
- MACD
- AKRO -0.27
- INTR 0.11
- Stochastic Oscillator
- AKRO 49.67
- INTR 86.90
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop & Commerce Plus. It generates maximum revenue from the Banking & Spending.